LEDERMAN SETH (Chief Executive Officer) purchased 124.8% of their position (5K shares) of TONIX PHARMACEUTICALS HOLDING CORP. on the open market
Open‑market purchase worth $58.9K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 6/9/2026ACC: 0001493152-26-027986
DirectorOfficer· Chief Executive Officer
Since Jun 2018
+5K
Net shares
Net buyer
$58.9K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
5K acquired
Non-Derivative Transactions1
Common Stock, $0.001 par value
Direct
Shares
+5K
Price / share
$11.79
Trade value
$58.95K
% of position
124.8%
6/9/2026
4K→9.01K
Total
Net shares
+5K
Net value
$58.95K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 par value Direct | 6/9/2026 | P · Purchase | +5K | $11.79 | $58.95K | 124.8% | 4K | 9.01K |
| Total | +5K | $58.95K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock, $0.001 par value
IndirectShares owned20K
Common Stock, $0.001 par value
IndirectShares owned1.00
Total
20K indirect20K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock, $0.001 par value | 20K | Indirect |
| Common Stock, $0.001 par value | 1.00 | Indirect |
| Total | 20K | 20K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported